Dr. Perlis currently consults with Anavex Pharmaceuticals and is an expert advisor for Gerson Lehman Group and Guidepoint.

 

His work is largely focused on the sleep effects of drugs and devices that are in development.

  • Sanofi

  • Merck 

  • Eisai

  • Actelion

  • Takeda

  • Nexalin

  • Lumosity

  • MedQuery Advisors

  • Intelligentsia Consulting

  • InsomniSolv

Michael Perlis PhD

Associate Professor of Psychiatry 

Associate Professor of Nursing

Director of the Behavioral Sleep Medicine Program, University of Pennsylvania

Email: mperlis@upenn.edu

Phone: 215-746-3577 

Penn website: www.med.upenn.edu/bsm/

The purpose of life cannot only be to make it safer, longer, and more enjoyable… 

it also must include the unrelenting search for, and discovery of, who, what, and where we are…  

only in this way is transcendence possible.